During the reunion of "Love Is Blind" Season 10, the show’s host, Nick Lachey, confronted contestant Chris Fusco for trying to move in on his friend Connor’s fiancée, violating what viewers quickly ...

Ravi Mohan’s upcoming film “Bro Code” is set to undergo a title change following a trademark dispute involving the production company and a beverage brand. The controversy emerged after Indo Spirit ...

Add Yahoo as a preferred source to see more of our stories on Google. Participants have to find out if Love Is Blind, and the answer was no for several season 10 cast members. The men also ...

Actor Ravi Mohan has decided to drop the title Bro Code from his upcoming film. This decision comes after a trademark dispute with IndoSpirit Beverages Private Limited, which had argued that the title ...

The actor has also withdrawn proceedings he had earlier initiated before the Madras High Court. Ravi Mohan’s upcoming film, also starring SJ Suryah and Arjun Ashokan, will no longer be titled Bro Code ...

Ravi Mohan's new movie had to ditch its original title, Bro Code, thanks to a trademark dispute with IndoSpirit Beverages. The studio shared that RaviMohan studios registered its copyright BroCode ...

Actor-producer Ravi Mohan’s upcoming film will no longer carry the title Bro Code, bringing an end to a prolonged legal tussle surrounding the name. The decision comes after the actor chose to ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...